1. European Agency for the Evaluation of Medicinal Products (EMEA). Position paper on the nonclinical safety studies to support clinical trials with a single microdose. CPMP/SWP2599/0.; 28 January 2003.
2. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Guidance for industry, investigators, and reviewers exploratory IND studies.; January 2006.
3. Ministry of Health, Labour and Welfare (MHLW), Japan. Guidance on microdose clinical trial (Pharmaceutical and Food Safety Bureau Notification No. 0603001).; 2008.
4. Gilbert J, Henske P, Singh A. Rebuilding big pharma’s business model. Windhover’s In Vivo. Bus Med Rep. 2003;21:73–82.
5. Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov. 2003;2:566–80.